Veradigm Issued Patent for Risk Adjustment Method and Apparatus
June 29 2022 - 8:01AM
Business Wire
Veradigm is providing health plans with a
patent-protected method to support risk adjustment programs through
“Dynamic Intervention Planning”
Veradigm, a business unit of Allscripts Healthcare Solutions
(NASDAQ: MDRX), today announced that its method and apparatus for
risk adjustment patent (“Dynamic Intervention Planning”) has been
issued by the United States Patent and Trademark Office
(USPTO).
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20220629005232/en/
The patent covers the systems that power Veradigm’s Dynamic
Intervention Planning process. These systems enable Veradigm’s
clients to find, size, monetize, prioritize, and resolve
opportunities across different lines of business.
“Dynamic Intervention Planning can result in a greater risk
adjustment lift for our clients. It allows our clients to properly
focus their efforts to be more impactful,” says Tom Langan,
President and Chief Commercial Officer of Veradigm. “This means
less waste, greater precision in revenue projections, and more
control over how our clients manage their programs.”
Through this patent, only Veradigm can identify service item
management opportunities, ascribe levels of confidence, and size
Risk Adjustment Factor points. This Veradigm Network solution can
also recommend and prioritize interventions, communicate
opportunities for action electronically to external devices, and
dynamically update all of this as the health plan member’s data
builds and refines over time.
About Veradigm®
Veradigm is a healthcare technology company that drives value
through its unique combination of platforms, data, expertise,
connectivity, and scale. Some healthcare technology companies
deliver clinical data for biopharma and health plans, some help
turn that data into insights, others serve healthcare providers
directly by providing point-of-care clinical software and patient
outreach platforms, Veradigm does all of these and more. The
Veradigm Network features a dynamic community of solutions and
partners providing advanced insights, technology, and data-driven
solutions, all working together to transform healthcare
insightfully.
For more information on Veradigm, visit www.veradigm.com, or
find Veradigm on LinkedIn, Facebook, Twitter, and YouTube.
About Allscripts
Allscripts (NASDAQ: MDRX) is a leader in healthcare information
technology solutions that advance clinical, financial and
operational results. Our innovative solutions connect people,
places and data across an Open, Connected Community of Health™.
Connectivity empowers caregivers to make better decisions and
deliver better care for healthier populations. To learn more, visit
www.allscripts.com, Twitter, YouTube and It
Takes A Community: The Allscripts Blog.
© 2022 Allscripts Healthcare, LLC and/or its affiliates. All
Rights Reserved.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220629005232/en/
Investors: Jenny Gelinas
312-506-1237 Jenny.Gelinas@allscripts.com
Media: Amanda Cohen 412-919-2417
Amanda.Cohen@veradigm.com
Veradigm (NASDAQ:MDRX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Veradigm (NASDAQ:MDRX)
Historical Stock Chart
From Jul 2023 to Jul 2024